Virtu Financial LLC Purchases New Holdings in Henry Schein, Inc. $HSIC

Key Points

• Virtu Financial LLC has acquired a new stake in Henry Schein, purchasing 7,109 shares valued at approximately $487,000 in the first quarter of 2023.
• Henry Schein reported a net profit margin of 3.05% with earnings per share of $1.10 for the last quarter, missing analysts' expectations by $0.09.
• Analysts have recently adjusted their price targets for Henry Schein, with a range of $75.00 to $78.00, and the stock holds an average rating of "Hold" among market experts.

Virtu Financial LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 7,109 shares of the company's stock, valued at approximately $487,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in Henry Schein in the 4th quarter valued at $34,720,000. Sterling Capital Management LLC grew its position in shares of Henry Schein by 55.4% in the fourth quarter. Sterling Capital Management LLC now owns 7,571 shares of the company's stock valued at $524,000 after purchasing an additional 2,700 shares during the last quarter. Barclays PLC increased its stake in shares of Henry Schein by 0.7% in the fourth quarter. Barclays PLC now owns 288,523 shares of the company's stock worth $19,964,000 after purchasing an additional 2,048 shares during the period. XTX Topco Ltd bought a new position in shares of Henry Schein in the fourth quarter worth about $296,000. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of Henry Schein during the 4th quarter worth about $95,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of HSIC traded down $0.07 during trading hours on Monday, hitting $67.78. The stock had a trading volume of 409,137 shares, compared to its average volume of 1,767,748. The stock has a market capitalization of $8.22 billion, a price-to-earnings ratio of 21.87, a P/E/G ratio of 2.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The company's fifty day moving average is $70.81 and its two-hundred day moving average is $70.72. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business's revenue was up 3.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.23 EPS. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

HSIC has been the topic of a number of research analyst reports. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wells Fargo & Company lowered their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Barrington Research dropped their target price on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Finally, UBS Group decreased their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Nine investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Henry Schein presently has an average rating of "Hold" and a consensus price target of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.